Software and data companies at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

14 software and data companies are at ASHG 2026 — 6 presentations on the program and 12 with a booth in the exhibit hall. Most represented: SeqOne (2 on the program), Genomenon (1 on the program), Google DeepMind (1 on the program). 13 of them have their own page in this guide. As of Sep 25, 2026.

All 1,062 organizations at ASHG 2026 →

Showing 1–14 of 14 organizations

Organization	ASHG 2026 Attendance
SeqOne Wilmington, Delaware	1 Data Science Engineer · 1 VP Product
seqone.com\|LinkedIn Private company~125 people SeqOne sells AI-powered NGS bioinformatics to molecular labs, helping them turn sequencing data into fast, actionable clinical insights. SeqOne's Spring 2026 release added 72 IVDR-certified features, including structural-variant and lab-automation capabilities, a compliance-ready upgrade. › SeqOne's Spring 2026 release added 72 IVDR-certified features, including structural-variant and lab-automation capabilities, a compliance-ready upgrade. 2026-04 · source SeqOne launched SomaLBx and SomaMethyl, two integrated solutions for in-house liquid-biopsy analysis in oncology. 2025-11 · source SeqOne agreed to acquire Congenica, a UK company spun out of the Wellcome Sanger Institute, expanding its clinical genomics reach. 2025-09 · source Source: company newsroom Raised €20M growth round (May 2025) › Led by Supernova Invest with Elaia, Omnes, and Mérieux Equity Partners; oversubscribed round. · 2025-05-22 “SeqOne today announced a significant €20 million oversubscribed growth funding round. Led by new investor Supernova Invest” Source: funding announcement Currently hiring: 3 open roles › Source: careers page	Booth Exhibiting at Booth 521 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Poster Wed Oct 21 2:30 pm ★ Reviewers’ Choice Part of Artificial Intelligence and Machine Learning Poster Wednesday Session Real-World Clinical Validation of DiagAI for WGS Interpretation in the NHS-GMS: Robust Prioritization and Rescue of Pseudogene-Masked Variants Exhibit & Poster Hall · Board 8100W BioinformaticsCharacterization of disordersComplex diseasesExome/genome sequencing Poster Fri Oct 23 2:30 pm Part of Artificial Intelligence and Machine Learning Poster Friday Session Detection and Classification of Uniparental Disomy from Clinical Whole-Exome Data Using the GermVar Pipeline Exhibit & Poster Hall · Board 8061F BioinformaticsClinical geneticsComplex diseasesCopy number/structural variation
Genomenon Ann Arbor, Michigan	1 Field Application Scientist
genomenon.com\|LinkedIn Genomenon sells genomic intelligence software, curated genomic data, and evidence services. It serves clinical laboratories, researchers, clinicians, and biopharma teams. Partnered with Amicus Therapeutics, which is sponsoring Genomenon's efforts to advance Fabry disease diagnosis and evidence generation. › Partnered with Amicus Therapeutics, which is sponsoring Genomenon's efforts to advance Fabry disease diagnosis and evidence generation. 2026-03 · source Appointed Kristin Fix as Senior Vice President of Sales, signaling a push to grow its commercial sales organization. 2025-11 · source Partnered with Compass Bioinformatics to integrate its Mastermind data into Compass's InheriNext platform, expanding reach into Japan's genetic-diagnostics market. 2025-09 · source Source: company newsroom Raised $5.3M financing round in March 2021 › Investors included BroadOak Capital, Green Park & Golf Ventures, Red Cedar Ventures, and Michigan Rise; no newer round stated. · 2021-03-16 “Genomenon announced that it has completed a $5.3M financing round in the company.” Source: funding announcement Currently hiring: 3 open roles › Source: careers page	Booth Exhibiting at Booth 726 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Poster Fri Oct 23 2:30 pm Part of Genetic, Genomic, and Epigenomic Resources and Databases Poster Friday Session Increases in Diagnostic Yield Through Partnership-Driven Literature Curation to Expand Public Variant Evidence: Case Studies in Fabry Disease, ENPP1 Deficiency, and PRKAG2 Syndrome Exhibit & Poster Hall · Board 4035F Artificial intelligenceDatabasesRare variants
Google DeepMind London, UK	1 Staff Research Engineer
deepmind.google\|LinkedIn Google DeepMind develops AI models and research platforms for scientists, developers, and organizations. Its life-science tools support protein-structure prediction and genomic variant interpretation. Released a free platform predicting effects of 9 billion possible DNA variants, a potential alternative to paid variant-interpretation tools. › Released a free platform predicting effects of 9 billion possible DNA variants, a potential alternative to paid variant-interpretation tools. 2026-09 · source Published a joint biosecurity positioning paper with sibling company Isomorphic Labs, not a new product or deal. 2026-07 · source Announced a research partnership with film studio A24; details are thin and it isn't clearly relevant to genomics work. 2026-06 · source Source: company newsroom Currently hiring: 94 open roles › Source: careers page	Booth Exhibiting (no floor booth listed) Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Talk Wed Oct 21 11:15 am Part of Promise and Peril of Sequence-to-Function Models for Variant Effect Predictions In silico saturation mutagenesis of the human genome with AlphaGenome improves variant prioritization and interpretation Room 517BC/Level 5 Genetic variationGenomicsMachine learningRare variants
Google Mountain View, California	1 Product Lead, Genomics
LinkedIn Subsidiary Google sells cloud AI platforms, machine-learning models, and data tools to businesses, developers, and researchers. Its research targets genomics and biomedical discovery. Announced Gemini for Science, a new AI platform built on its research assistance and Co-Scientist tools, aimed at researchers. › Announced Gemini for Science, a new AI platform built on its research assistance and Co-Scientist tools, aimed at researchers. 2026-05 · source Opened its Empirical Research Assistance tool to a trusted tester program in Google Labs, a step toward wider release. 2026-05 · source Developed DeepSomatic, a genomic analysis tool designed to more accurately identify cancer-related genetic mutations. 2026-03 · source Source: company newsroom Alphabet Q4 2025 revenue $113.8B, up 18%; 2026 capex $175-185B › Figures are for parent Alphabet overall; heavy planned capex signals continued AI infrastructure investment. · 2026-02-04 “Consolidated Alphabet revenues increased 18%, or 17% in constant currency, to $113.8 billion. Our 2026 CapEx investments are anticipated to be in the range of $175 to $185 billion.” Source: results release Currently hiring: 1,946 open roles › Source: careers page	Symposium Fri Oct 23 8:20 am Part of AI Across the Diagnostic Odyssey: From Variant Interpretation to Computable Phenotypes Using specialist AI to identify variants in DNA sequence data and generalist AI to predict effects Room 517A/Level 5
Nvidia Santa Clara, California	1 Senior Bioinformatics Scientist
nvidia.com\|LinkedIn Public company~42,000 people NVIDIA sells GPU-accelerated computing, AI platforms, and genomics software to healthcare and life-sciences developers, researchers, and organizations. Expanded AI data-center infrastructure partnerships in Australia, growing compute capacity available for genomics and life-sciences AI workloads there. › Expanded AI data-center infrastructure partnerships in Australia, growing compute capacity available for genomics and life-sciences AI workloads there. 2026-09 · source Agreed to acquire AI platform Hugging Face for about $12.9 billion, consolidating its position across the AI model ecosystem. 2026-09 · source Deepened a cybersecurity collaboration with CrowdStrike around agentic AI, a security-focused move with no direct genomics angle. 2026-09 · source Source: company newsroom Q2 FY2027 revenue $96.2B, up 106% YoY › Guided Q3 FY2027 revenue to about $108 billion, reflecting continued AI-compute demand. · 2026-08-26 “Revenue of $96.2 billion, up 106% from a year ago. Revenue is expected to be $108.0 billion, plus or minus 2%.” Source: results release Currently hiring › Source: careers page	Poster Fri Oct 23 2:30 pm Part of Artificial Intelligence and Machine Learning Poster Friday Session GPU-Accelerated DeepSAP: Fast and Accurate Transformer-Based RNA-Seq Alignment Exhibit & Poster Hall · Board 8075F Collaborators: Genentech Alternative splicingArtificial intelligenceBioinformaticsComputational tools
Advaita Bioinformatics Ann Arbor, Michigan
advaitabio.com\|LinkedIn Advaita sells cloud-based bioinformatics software to academic, biotech, and pharmaceutical researchers. Its platforms interpret multi-omics, single-cell, and spatial transcriptomics data. Launched iSCanGuide, a GPU-accelerated cloud platform for analyzing large single-cell and spatial transcriptomics datasets, a new bioinformatics product. › Launched iSCanGuide, a GPU-accelerated cloud platform for analyzing large single-cell and spatial transcriptomics datasets, a new bioinformatics product. 2026-05 · source Source: company newsroom Received $1.7M NIH award (Jan 2024) › Grant funds development of a single-cell data analysis platform; no funding round was disclosed. · 2024-01-30 “Advaita Bio was awarded $1.7 million from the National Institute of Health (NIH) to develop a new platform for the analysis of single-cell data.” Source: funding announcement No openings posted	Booth Exhibiting at Booth 1711 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Amazon Web Services (AWS)
aboutamazon.com\|LinkedIn Subsidiary AWS sells cloud infrastructure, AI, analytics, and genomics services to biopharma, diagnostics, research, and healthcare organizations. Made its HealthOmics genomics service generally available in Tokyo, expanding a cloud platform for storing and analyzing genomic data in Asia. › Made its HealthOmics genomics service generally available in Tokyo, expanding a cloud platform for storing and analyzing genomic data in Asia. 2026-07 · source Partnered with VC firm Sofinnova to embed AI across its life-sciences investment platform and portfolio companies. 2026-06 · source Partnered with Flagship Pioneering to accelerate drug discovery and life-sciences innovation across its portfolio companies. 2026-04 · source Source: company newsroom Q2 2026 AWS revenue $42.2B, up 37% YoY › AWS-specific guidance wasn't given; Amazon guided total Q3 2026 sales to $197-202 billion. · 2026-07-30 “AWS segment sales increased 37% year-over-year to $42.2 billion. Net sales are expected to be between $197.0 billion and $202.0 billion.” Source: results release Currently hiring › Source: careers page	Booth Exhibiting (no floor booth listed) Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Deriva.ai Haifa, Israel
deriva.ai\|LinkedIn Deriva is a platform designed for genomics and clinical services.	Booth Exhibiting at Booth 1725 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
DNAnexus Mountain View, California
dnanexus.com\|LinkedIn Private company~230 people DNAnexus provides customers a centralized platform for omics and phenotypic data management, workflow automation, security, compliance, and access controls. Was named to the 2026 Inc. 5000 fastest-growing companies list, a signal of strong recent growth. › Was named to the 2026 Inc. 5000 fastest-growing companies list, a signal of strong recent growth. 2026-08 · source Reported a 90% customer satisfaction score while expanding its AI platform capabilities, suggesting stable relationships during a product push. 2026-07 · source Launched new AI-powered precision-health products and solution packages, expanding its genomics data-management platform for biopharma and health-system customers. 2026-05 · source Source: company newsroom Raised $200M funding (Mar 2022) › Led by Blackstone Growth, with Northpond Ventures, GV, Perceptive Advisors, Innovatus, and Foresite Capital. · 2022-03-08 “DNANEXUS SECURES $200 MILLION FUNDING LED BY BLACKSTONE GROWTH” Source: funding announcement	Booth Exhibiting at Booth 1010 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Geneyx Wilmington, Delaware
geneyx.com\|LinkedIn Private company Geneyx sells AI-based software for WES, WGS, gene-panel, and multiomics analysis. Customers include genetics labs, researchers, and life-science companies. Released Geneyx Analysis 6.3, adding workflow, API, and structural-variant capabilities that expand what labs can analyze. › Released Geneyx Analysis 6.3, adding workflow, API, and structural-variant capabilities that expand what labs can analyze. 2026-04 · source Released Geneyx Analysis 6.2.1, adding DRAGEN support plus CNV and structural-variant enhancements for labs' pipelines. 2025-12 · source Partnered with Omics Discoveries to advance integrated DNA-RNA analysis, combining functional genomics capabilities for shared customers. 2025-10 · source Source: company newsroom Raised $6.5M seed funding in 2021 (last stated round) › No newer funding announced since; a 2021 seed round is the most recent publicly stated figure. · 2021 “raised $6.5 million in a seed funding round in 2021.” Source: funding announcement Currently hiring: 2 open roles › Source: careers page	Booth Exhibiting at Booth 311 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Golden Helix Bozeman, Montana
goldenhelix.com\|LinkedIn Golden Helix provides the complete NGS analysis software stack for diagnostic laboratories running panels, exomes, and whole genomes at clinical scale. Signed an agreement to bring its genomic analysis software to multiple Austrian public medical genetics labs, expanding its clinical footprint. › Signed an agreement to bring its genomic analysis software to multiple Austrian public medical genetics labs, expanding its clinical footprint. 2026-03 · source Released VarSeq 3.0.0 with full integration into VSWarehouse 3, adding a new login system supporting both single-user and server-managed authentication. 2025-11 · source Partnered with Genomenon to integrate its Mastermind genomic intelligence platform and Cancer Knowledgebase into the Golden Helix software suite. 2025-09 · source Source: company newsroom No openings posted	Booth Exhibiting at Booth 525 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Shorthills AI Gurugram, India
shorthills.ai\|LinkedIn ~300 people Shorthills AI sells custom AI agents, data hubs, and workflow software to healthcare, life-sciences, and enterprise teams. Became a Snowflake Select Tier services partner, signaling deeper integration with Snowflake's data cloud stack. › Became a Snowflake Select Tier services partner, signaling deeper integration with Snowflake's data cloud stack. 2026-03 · source Partnered with IBM to build a production-grade legal search system, an enterprise AI project outside life sciences. 2026-02 · source Became an AWS Select Tier services partner, another sign of its cloud-platform integrations. 2026-01 · source Source: company newsroom Currently hiring: 6 open roles › Source: careers page	Booth Exhibiting at Booth 1611 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
VarSome Lausanne, Switzerland
varsome.com\|LinkedIn VarSome sells bioinformatics software for variant annotation, classification, and interpretation. It serves research, clinical, and diagnostic genomics teams. Added a known-structural-variant overlap feature to VarSome Clinical, improving copy-number-variant interpretation for labs. › Added a known-structural-variant overlap feature to VarSome Clinical, improving copy-number-variant interpretation for labs. 2026-03 · source Added RNA fusion annotation to VarSome Clinical, built for routine somatic oncology workflows. 2026-03 · source Its parent company Saphetor appointed Esteban Czwan as Chief Commercial Officer, effective December 2025. 2025-12 · source Source: company newsroom Currently hiring: 15 open roles › Source: careers page	Booth Exhibiting at Booth 1016 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm
Velsera/Seven Bridges Boston, MA
velsera.com\|LinkedIn Velsera sells bioinformatics, data-harmonization, and clinical NGS interpretation software plus expert services to biopharma, researchers, and diagnostic laboratories. Appointed Kareem Saad as President and Chief Business Officer. › Appointed Kareem Saad as President and Chief Business Officer. 2026-05 · source Appointed Jamie Coffin as Chief Executive Officer, a leadership change worth watching for strategic shifts. 2026-01 · source Expanded its Global Data Network, growing access to real-world longitudinal clinicogenomic data for pharma and biotech customers. 2025-06 · source Source: company newsroom	Booth Exhibiting at Booth 408 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm